O
Olivier Dellis
Researcher at Université Paris-Saclay
Publications - 31
Citations - 1175
Olivier Dellis is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Jurkat cells & Endoplasmic reticulum. The author has an hindex of 16, co-authored 30 publications receiving 1080 citations. Previous affiliations of Olivier Dellis include Pierre-and-Marie-Curie University & University of Reims Champagne-Ardenne.
Papers
More filters
Journal ArticleDOI
Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium–Phosphate Cotransporter
Dominique Prié,Virginie Huart,Naziha Bakouh,Gabrielle Planelles,Olivier Dellis,Bénédicte Gérard,Philippe Hulin,François Benqué-Blanchet,Caroline Silve,Bernard Grandchamp,Gérard Friedlander +10 more
TL;DR: Heterozygous mutations in the NPT2a gene may be responsible for hypophosphatemia and urinary phosphate loss in persons with urolithiasis or bone demineralization.
Journal ArticleDOI
Ca2+ entry through plasma membrane IP3 receptors.
Olivier Dellis,Skarlatos G. Dedos,Stephen C. Tovey,Taufiq-Ur-Rahman,Stefan J. Dubel,Colin W. Taylor +5 more
TL;DR: Inositol 1,4,5-trisphosphate receptors are unusual among endoplasmic reticulum proteins in being also functionally expressed at the PM, where very few IP3Rs contribute substantially to the Ca2+ entry evoked by the BCR.
Journal ArticleDOI
Plasma Membrane Depolarization Induced by Abscisic Acid in Arabidopsis Suspension Cells Involves Reduction of Proton Pumping in Addition to Anion Channel Activation, Which Are Both Ca2+ Dependent
Mathias Brault,Zahia Amiar,A. M. Pennarun,M. Monestiez,Zongshen Zhang,Daniel Cornel,Olivier Dellis,Heather Knight,François Bouteau,Jean-Pierre Rona +9 more
TL;DR: It is found that ABA causes simultaneously cell depolarization and medium alkalinization, the second effect being abolished when ABA is added in the presence of H+ pump inhibitors.
Journal ArticleDOI
Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2
Khalil El Karoui,Amandine Viau,Olivier Dellis,Alessia Bagattin,Clément Nguyen,William Baron,Martine Burtin,Melanie Broueilh,Laurence Heidet,Géraldine Mollet,Anne Druilhe,Corinne Antignac,Bertrand Knebelmann,Gérard Friedlander,Frank Bienaimé,Morgan Gallazzini,Fabiola Terzi +16 more
TL;DR: 4-phenylbutyric acid (PBA), a chemical chaperone already used in humans, is identified as a novel therapeutic strategy capable to counteract the toxic effect of proteinuria to improve the benefit of RAS inhibitors in proteinuria-induced CKD progression.
Journal ArticleDOI
Synthetic partial agonists reveal key steps in IP3 receptor activation.
Ana M. Rossi,Andrew M. Riley,Stephen C. Tovey,Taufiq Rahman,Olivier Dellis,Emily J. A. Taylor,Valery G Veresov,Barry V. L. Potter,Colin W. Taylor +8 more
TL;DR: 2-O-modified IP3 analogues are synthesized that are partial agonists of IP3R that are less effective than IP3 in rearranging the relationship between the IBC and N-terminal suppressor domain (SD), and they open the channel at slower rates.